|
RLMD Relmada Therapeutics Inc 1553643 |
| Balance Sheet |
|
Current Assets
|
55,702,530 |
|
Assets
|
55,724,505 |
|
Current Liabilities
|
8,086,761 |
|
Liabilities
|
8,099,323 |
|
Equity
|
47,625,182 |
|
Shares Out
|
30,174,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-42,956,164 |
|
Investing Cash Flow
|
40,216,239 |
| Market Analysis |
Market Cap
|
105,911,441 |
|
Price
|
0.37 |
|
BVPS
|
1.58 |
|
PB
|
0.23 |
|
EPS
|
-2.88 |
|
PS
|
0.85 |
|
FCF
|
-2,739,925 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RLMD documents filed with the SEC.
RLMD Filings
Clear
